[ad_1]
Dubai, United Arab Emirates (CNN) – The U.S. Food and Drug Administration (FDA) on Monday granted full approval for Pfizer-Biontech’s Corona virus vaccine for people 16 years of age or older.
This is the first Corona virus vaccine to be fully approved and not just for emergency use by the United States Food and Drug Administration.
The Food and Drug Administration said in a statement Monday that “the vaccine, known as Pfizer-Biontech, will now be marketed as Kommernate, to protect people over 16 from Covid-19 disease “.
The Pfizer-Biontech vaccine has been cleared for emergency use in America since mid-December, for people 16 years of age and older.
In May, the mandate was extended to 12 years and over.
The FDA clarified that “the vaccine is also still available under an emergency use license, including for people aged 12 to 15, and to provide a third dose for people who are immunocompromised.”
Of the more than 170 million people in the United States who have been fully vaccinated against COVID-19, more than 92 million have received the Pfizer-Biontech vaccine.
And this weekend, officials familiar with the decision said they discussed how to prepare for the launch after the Food and Drug Administration gives full approval, given that it would be an opportunity to encourage the launch. vaccination.
U.S. Surgeon General Dr Vivek Murthy told CNN’s State of the Union on Sunday that the approval could encourage more people to receive the vaccinations and more warrants.
Murthy also noted that “a small number of people” waited for full approval before getting the vaccine and believed that “it might push them to get the vaccine.”
Moderna is seeking full approval for a COVID-19 vaccine for people 18 and older.
Johnson & Johnson has yet to seek full approval from the U.S. Food and Drug Administration for its vaccine.
Some experts have pushed the Food and Drug Administration to approve vaccines quickly, as it could help fight vaccine hesitation.
Full COVID-19 dose approval comes days after the Biden administration announced plans to provide booster doses to vaccinated adults from September 20, pending approval from the Food and Drug Administration and a recommendation from the United States Centers for Disease Control and Prevention.
So far, the Pfizer-Biontech coronavirus vaccine has been available for people 12 years of age or older in the United States.
Pfizer expects to have data from vaccine trials in children aged 5 to 11 by the end of September.
The company can apply for permission to offer its vaccine to younger people soon after.
The company also said data for young children, aged two to five, may be available soon.
Source link
